TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 121.37%1.42B | ---- | -45.39%639.53M | ---- | 65.56%1.17B | ---- | 18.22%707.4M | ---- | 352.42%598.38M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -421.87%-151.88M | ---- | -295.26%-29.1M | ---- | ---7.36M | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | -22.86%-33.23M | ---- | -92.97%-27.05M | ---- | -261.89%-14.02M | ---- | 22.07%-3.87M | ---- | -418.25%-4.97M |
Impairment and provisions: | ---- | -4.81%8.76M | ---- | 234.33%9.2M | ---- | 62.23%2.75M | ---- | -77.19%1.7M | ---- | 1,482.98%7.44M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --467K | ---- | ---- | ---- | ---- | ---- | --2.64M |
-Impairmen of inventory (reversal) | ---- | 117.12%8.02M | ---- | 180.12%3.69M | ---- | -37.09%1.32M | ---- | 22.51%2.1M | ---- | 755.00%1.71M |
-Other impairments and provisions | ---- | -85.23%745K | ---- | 251.57%5.05M | ---- | 460.55%1.44M | ---- | -112.90%-398K | ---- | 1,042.96%3.09M |
Revaluation surplus: | ---- | 87.65%-6.11M | ---- | -224.20%-49.48M | ---- | -398.84%-15.26M | ---- | 404.35%5.11M | ---- | -105.89%-1.68M |
-Other fair value changes | ---- | 87.65%-6.11M | ---- | -224.20%-49.48M | ---- | -398.84%-15.26M | ---- | 404.35%5.11M | ---- | -105.89%-1.68M |
Asset sale loss (gain): | ---- | 1,189.34%2.54M | ---- | 6,466.67%197K | ---- | -97.46%3K | ---- | 188.72%118K | ---- | -154.51%-133K |
-Loss (gain) on sale of property, machinery and equipment | ---- | 1,189.34%2.54M | ---- | 6,466.67%197K | ---- | -81.25%3K | ---- | 112.03%16K | ---- | -154.51%-133K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --102K | ---- | ---- |
Depreciation and amortization: | ---- | 10.54%668.57M | ---- | 39.04%604.82M | ---- | 76.94%435M | ---- | 126.16%245.84M | ---- | 156.42%108.7M |
-Amortization of intangible assets | ---- | 7.57%86.88M | ---- | 56.93%80.77M | ---- | 42.10%51.47M | ---- | 311.65%36.22M | ---- | 104.87%8.8M |
Financial expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 66.88%8.99M | ---- | 132.99%5.39M |
Exchange Loss (gain) | ---- | -369.96%-1.5M | ---- | -78.72%556K | ---- | 105.75%2.61M | ---- | 3.59%1.27M | ---- | 61,400.00%1.23M |
Special items | ---- | 4.10%101.75M | ---- | -33.54%97.74M | ---- | 769.71%147.07M | ---- | 1,052.69%16.91M | ---- | 87.60%1.47M |
Operating profit before the change of operating capital | ---- | 60.83%2B | ---- | -27.62%1.25B | ---- | 75.09%1.72B | ---- | 37.39%983.47M | ---- | 305.14%715.82M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 63.90%-29.55M | ---- | 85.51%-81.85M | ---- | -333.35%-564.78M | ---- | -89.02%-130.33M | ---- | -402.52%-68.95M |
Accounts receivable (increase)decrease | ---- | -352.33%-122.73M | ---- | 82.90%-27.13M | ---- | -124.76%-158.68M | ---- | -7.31%-70.6M | ---- | -205.22%-65.79M |
Accounts payable increase (decrease) | ---- | 197.77%287.55M | ---- | -51.31%96.57M | ---- | 62.14%198.31M | ---- | 29.83%122.31M | ---- | 63.09%94.21M |
prepayments (increase)decrease | ---- | 71.21%-20.06M | ---- | 63.42%-69.67M | ---- | -254.37%-190.45M | ---- | 44.58%-53.74M | ---- | -364.53%-96.98M |
Special items for working capital changes | ---- | 175.73%23.35M | ---- | -186.39%-30.83M | ---- | -26.84%35.68M | ---- | 94.10%48.77M | ---- | 168.92%25.13M |
Cash from business operations | 71.36%1.91B | 89.08%2.14B | 112.74%1.11B | 8.77%1.13B | -5.65%523.39M | 15.80%1.04B | 152.31%554.71M | 49.13%899.88M | 17.61%219.86M | 221.59%603.44M |
Other taxs | -98.29%-194.04M | -7.35%-262.07M | 35.46%-97.86M | 16.27%-244.13M | -19.45%-151.62M | -46.91%-291.59M | -29.05%-126.94M | -96.57%-198.48M | -136.29%-98.36M | -689.65%-100.97M |
Interest received - operating | 149.34%191.28M | 6,509.72%109.46M | 4,136.06%76.72M | -94.21%1.66M | -86.96%1.81M | 1,364.87%28.61M | 1,886.84%13.89M | 360.61%1.95M | 732.14%699K | 196.50%424K |
Net cash from operations | 74.42%1.91B | 123.41%1.99B | 192.40%1.09B | 14.37%891.02M | -15.41%373.58M | 10.77%779.1M | 261.45%441.66M | 39.86%703.36M | -15.96%122.19M | 187.37%502.89M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | --15.62M | 3.77%8.86M | ---- | 311.67%8.54M | ---- | --2.07M | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | 69.73%492.23M | 114.28%612.55M | 107.28%290M | ---4.29B | 6.54%-3.99B | ---- | ---4.26B | ---- | ---- | ---- |
Sale of fixed assets | 723.53%2.24M | -63.35%866K | -94.51%272K | 288.01%2.36M | -68.92%4.95M | -77.55%609K | --15.93M | --2.71M | ---- | ---- |
Purchase of fixed assets | 15.41%-157.86M | -21.81%-324.18M | -37.36%-186.62M | 7.43%-266.13M | -18.81%-135.86M | -63.37%-287.5M | -101.68%-114.35M | -67.68%-175.98M | -102.62%-56.7M | -195.89%-104.95M |
Purchase of intangible assets | -4.10%-28.59M | 16.20%-68.29M | -4.61%-27.46M | -76.21%-81.49M | -110.70%-26.25M | 2.86%-46.25M | 25.95%-12.46M | -279.32%-47.61M | -104.63%-16.83M | 19.30%-12.55M |
Acquisition of subsidiaries | ---- | --6.49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | 10.31%956.53M | -43.87%810.24M | -14.73%867.14M | 51.02%1.44B | 13.76%1.02B | 239.36%955.82M | 223.77%893.95M | 9.60%281.65M | 137.08%276.1M | 183.92%256.98M |
Cash on investment | -9.90%-946.59M | 46.36%-812.6M | 20.59%-861.3M | -19.03%-1.52B | -6.57%-1.08B | -355.70%-1.27B | -303.21%-1.02B | -8.36%-279.3M | -272.87%-252.42M | -84.10%-257.75M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.59M | --1.59M | ---- |
Net cash from investment operations | 306.65%333.59M | 104.98%233.94M | 101.95%82.03M | -625.06%-4.7B | 6.41%-4.21B | -198.71%-648M | -9,221.38%-4.5B | -83.43%-216.94M | -484.44%-48.26M | -17.67%-118.27M |
Net cash before financing | 90.64%2.24B | 158.43%2.22B | 130.61%1.17B | -3,004.30%-3.81B | 5.43%-3.84B | -73.05%131.1M | -5,587.14%-4.06B | 26.47%486.42M | -53.19%73.93M | 416.34%384.62M |
Cash flow from financing activities | ||||||||||
Refund | ---15.06M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.16B | --86.56M | ---- |
Dividends paid - financing | -213.48%-373.03M | 44.74%-121.61M | 46.21%-119M | -5.39%-220.09M | -725.47%-221.2M | 44.69%-208.83M | ---26.8M | -371.98%-377.58M | ---- | ---80M |
Absorb investment income | ---- | --3.57M | ---- | ---- | ---- | ---- | ---- | 136.35%398.38M | --398.38M | 324.54%168.55M |
Issuance expenses and redemption of securities expenses | 68.39%-78.03M | 47.39%-333.71M | -105.72%-246.88M | -9,137.08%-634.31M | ---120.01M | 95.57%-6.87M | ---- | -56,849.26%-154.9M | 30.00%-119K | ---272K |
Other items of the financing business | ---- | ---4.81M | ---- | ---- | ---- | ---- | ---- | 97.28%-4.57M | ---4.57M | ---168.09M |
Net cash from financing operations | -28.24%-715.97M | 28.53%-841.56M | -16.17%-558.29M | -170.16%-1.18B | -297.16%-480.56M | -108.95%-435.83M | -128.55%-121M | 3,230.38%4.87B | 498.74%423.76M | -1,884.63%-155.58M |
Effect of rate | -95.43%7.86M | -97.62%9.63M | 34.83%171.98M | 465.93%405.43M | 11,138.33%127.56M | -9,321.17%-110.79M | 284.25%1.14M | 4.08%-1.18M | -6,060.00%-616K | -61,400.00%-1.23M |
Net Cash | 147.19%1.52B | 127.74%1.38B | 114.27%616.08M | -1,535.81%-4.98B | -3.33%-4.32B | -105.69%-304.73M | -939.43%-4.18B | 2,238.82%5.36B | 863.24%497.69M | 175.26%229.04M |
Begining period cash | 203.21%2.08B | -86.98%685.31M | -86.98%685.31M | -7.32%5.26B | -7.32%5.26B | 1,649.84%5.68B | 1,649.84%5.68B | 235.34%324.61M | 235.34%324.61M | 612.20%96.8M |
Cash at the end | 144.92%3.61B | 203.21%2.08B | 37.01%1.47B | -86.98%685.31M | -28.48%1.08B | -7.32%5.26B | 82.99%1.5B | 1,649.84%5.68B | 453.47%821.69M | 235.34%324.61M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.